Showing results (1231-1240 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|December 30, 2011
Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction arrayXinghua Jin, Xiu-Xian Wu, Chenglou Jin, et al.
Anti-Cancer Drugs|March 17, 2012
A dramatic fetal outcome following transplacental transfer of dasatinibPaul Berveiller, Annalisa Andreoli, Olivier Mir, et al.
Anti-Cancer Drugs|March 3, 2012
Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cellsAngel Mauricio Castro-Gamero, Kleiton Silva Borges, Vanessa da Silva Silveira, et al.
Anti-Cancer Drugs|March 13, 2012
Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cellsMonika Garg, Jitender Madan, Ravi Shankar Pandey, et al.
Anti-Cancer Drugs|March 13, 2012
Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?Patrick G Morris
Anti-Cancer Drugs|October 2, 2008
Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulationJolie Kiemlian Kwee, Diogo Gomes Luque, Ana Carolina dos Santos Ferreira, et al.
Anti-Cancer Drugs|October 2, 2008
Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenograftsMarianne Labussière, Alice Aarnink, Sophie Pinel, et al.
Anti-Cancer Drugs|September 4, 2008
Impact of naringenin on glycoprotein levels in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in ratsGanapathy Ekambaram, Peramaiyan Rajendran, Rajasekaran Devaraja, et al.
Anti-Cancer Drugs|September 4, 2008
Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphomaLuis Villela, Mauricio García, Rocío Caballero, et al.
Anti-Cancer Drugs|September 4, 2008
A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 aloneKenji Ishido, Wasaburo Koizumi, Satoshi Tanabe, et al.
Pageof 464